1. Home
  2. MRKR vs CETY Comparison

MRKR vs CETY Comparison

Compare MRKR & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • CETY
  • Stock Information
  • Founded
  • MRKR N/A
  • CETY 1993
  • Country
  • MRKR United States
  • CETY United States
  • Employees
  • MRKR N/A
  • CETY N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • CETY Power Generation
  • Sector
  • MRKR Health Care
  • CETY Utilities
  • Exchange
  • MRKR Nasdaq
  • CETY Nasdaq
  • Market Cap
  • MRKR 35.8M
  • CETY 41.0M
  • IPO Year
  • MRKR N/A
  • CETY N/A
  • Fundamental
  • Price
  • MRKR $3.50
  • CETY $0.70
  • Analyst Decision
  • MRKR Strong Buy
  • CETY
  • Analyst Count
  • MRKR 1
  • CETY 0
  • Target Price
  • MRKR $19.00
  • CETY N/A
  • AVG Volume (30 Days)
  • MRKR 34.9K
  • CETY 133.5K
  • Earning Date
  • MRKR 11-22-2024
  • CETY 11-26-2024
  • Dividend Yield
  • MRKR N/A
  • CETY N/A
  • EPS Growth
  • MRKR N/A
  • CETY N/A
  • EPS
  • MRKR N/A
  • CETY N/A
  • Revenue
  • MRKR $3,727,435.00
  • CETY $13,548,613.00
  • Revenue This Year
  • MRKR $35.94
  • CETY N/A
  • Revenue Next Year
  • MRKR N/A
  • CETY N/A
  • P/E Ratio
  • MRKR N/A
  • CETY N/A
  • Revenue Growth
  • MRKR N/A
  • CETY 296.83
  • 52 Week Low
  • MRKR $2.44
  • CETY $0.45
  • 52 Week High
  • MRKR $6.16
  • CETY $2.39
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 46.47
  • CETY 41.42
  • Support Level
  • MRKR $3.52
  • CETY $0.61
  • Resistance Level
  • MRKR $3.90
  • CETY $1.27
  • Average True Range (ATR)
  • MRKR 0.40
  • CETY 0.09
  • MACD
  • MRKR -0.08
  • CETY 0.02
  • Stochastic Oscillator
  • MRKR 0.00
  • CETY 18.18

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: